"use strict";(self.webpackChunkstudyu_docs=self.webpackChunkstudyu_docs||[]).push([[364],{3905:(e,t,n)=>{n.d(t,{Zo:()=>d,kt:()=>m});var r=n(7294);function a(e,t,n){return t in e?Object.defineProperty(e,t,{value:n,enumerable:!0,configurable:!0,writable:!0}):e[t]=n,e}function i(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function o(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?i(Object(n),!0).forEach((function(t){a(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):i(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}function s(e,t){if(null==e)return{};var n,r,a=function(e,t){if(null==e)return{};var n,r,a={},i=Object.keys(e);for(r=0;r<i.length;r++)n=i[r],t.indexOf(n)>=0||(a[n]=e[n]);return a}(e,t);if(Object.getOwnPropertySymbols){var i=Object.getOwnPropertySymbols(e);for(r=0;r<i.length;r++)n=i[r],t.indexOf(n)>=0||Object.prototype.propertyIsEnumerable.call(e,n)&&(a[n]=e[n])}return a}var l=r.createContext({}),c=function(e){var t=r.useContext(l),n=t;return e&&(n="function"==typeof e?e(t):o(o({},t),e)),n},d=function(e){var t=c(e.components);return r.createElement(l.Provider,{value:t},e.children)},f="mdxType",u={inlineCode:"code",wrapper:function(e){var t=e.children;return r.createElement(r.Fragment,{},t)}},p=r.forwardRef((function(e,t){var n=e.components,a=e.mdxType,i=e.originalType,l=e.parentName,d=s(e,["components","mdxType","originalType","parentName"]),f=c(n),p=a,m=f["".concat(l,".").concat(p)]||f[p]||u[p]||i;return n?r.createElement(m,o(o({ref:t},d),{},{components:n})):r.createElement(m,o({ref:t},d))}));function m(e,t){var n=arguments,a=t&&t.mdxType;if("string"==typeof e||a){var i=n.length,o=new Array(i);o[0]=p;var s={};for(var l in t)hasOwnProperty.call(t,l)&&(s[l]=t[l]);s.originalType=e,s[f]="string"==typeof e?e:a,o[1]=s;for(var c=2;c<i;c++)o[c]=n[c];return r.createElement.apply(null,o)}return r.createElement.apply(null,n)}p.displayName="MDXCreateElement"},3420:(e,t,n)=>{n.r(t),n.d(t,{assets:()=>c,contentTitle:()=>s,default:()=>u,frontMatter:()=>o,metadata:()=>l,toc:()=>d});var r=n(7462),a=(n(7294),n(3905));const i=n.p+"assets/images/nof1_trial_transp-a91c6e7fe88f8adfd16f6bd26c82c745.png",o={},s="The Concept of N-of-1 Trials",l={unversionedId:"basics/n-of-1-trials",id:"basics/n-of-1-trials",title:"The Concept of N-of-1 Trials",description:"Traditionally, in our health system, treatment guidelines and health recommendations have been developed based on results of studies of large groups of individuals. However, the analysis of such large population-based studies only gives insights into factors affecting diseases and treatments on average. Hence, these results do not allow meaningful predictions whether an intervention will help a given single individual. For example, major drugs in therapeutic areas including asthma, depression, diabetes or rheumatoid arthritis have only shown an efficacy in 50%-60% of patients. Similarly, the effect of health interventions and lifestyle changes on chronic disease and health outcomes on an individual level if often unclear.",source:"@site/docs/02-basics/01-n-of-1-trials.md",sourceDirName:"02-basics",slug:"/basics/n-of-1-trials",permalink:"/de/docs/basics/n-of-1-trials",draft:!1,tags:[],version:"current",sidebarPosition:1,frontMatter:{},sidebar:"tutorialSidebar",previous:{title:"Basics",permalink:"/de/docs/category/basics"},next:{title:"The StudyU Platform",permalink:"/de/docs/basics/studyu-platform"}},c={},d=[],f={toc:d};function u(e){let{components:t,...n}=e;return(0,a.kt)("wrapper",(0,r.Z)({},f,n,{components:t,mdxType:"MDXLayout"}),(0,a.kt)("h1",{id:"the-concept-of-n-of-1-trials"},"The Concept of N-of-1 Trials"),(0,a.kt)("img",{src:i,style:{width:"30%",float:"right",marginLeft:"1em"}}),(0,a.kt)("p",null,"Traditionally, in our health system, treatment guidelines and health recommendations have been developed based on results of studies of large groups of individuals. However, the analysis of such large population-based studies only gives insights into factors affecting diseases and treatments on average. Hence, these results do not allow meaningful predictions whether an intervention will help a given single individual. For example, major drugs in therapeutic areas including asthma, depression, diabetes or rheumatoid arthritis have only shown an efficacy in 50%-60% of patients. Similarly, the effect of health interventions and lifestyle changes on chronic disease and health outcomes on an individual level if often unclear."),(0,a.kt)("p",null,"N-of-1 trials provide a framework to evaluate personalized treatments and derive invididual treatment effects. More specifically, N-of-1 trials are multi-crossover randomized controlled trials in a single participant, i.e. where the participant follows the different interventions of the study in a pre-specified or randomized order, and the outcome (e.g. improvement of lower back pain or rheumatoid arthritis pain) is compared between interventions."),(0,a.kt)("p",null,"Here, we are building a platform called StudyU, developing and evaluating necessary tools and methods for the platform, and applying the platform to derive and evaluate individualized treatment effects."))}u.isMDXComponent=!0}}]);